Fujian Septwolves Industry Co., Ltd. (002029) Wins Procurement Contract from China Life Insurance Fujian Branch Worth 2.28 Million Yuan

Deep News
Sep 08

According to data from Qichacha, based on the "China Life Fujian Branch 2025-2026 City and County Customer Service Center Staff Uniform Centralized Procurement Project Results Announcement," Fujian Septwolves Industry Co., Ltd. announced on September 8, 2025, that it has successfully won the procurement contract from China Life Insurance Company Limited Fujian Branch, with a contract value of 2.2844 million yuan.

Related listed company: Fujian Septwolves Industry Co., Ltd. (002029.SZ)

Financial Snapshot: For fiscal year 2024, Fujian Septwolves Industry Co., Ltd. (002029.SZ) recorded operating revenue of 3.14 billion yuan, representing a decline of 8.84% year-over-year. Net profit attributable to shareholders reached 285 million yuan, showing growth of 5.35%, while return on equity stood at 4.38%. In the first quarter of 2025, the company generated operating revenue of 844 million yuan, down 5.47% compared to the same period last year, while net profit attributable to shareholders reached 150 million yuan, surging 40.63% year-over-year.

The company operates in the discretionary consumer goods sector, with main product categories including industrial textiles, underwear, and outerwear. According to the 2024 annual report, the main business composition includes: Other products (27.98%), Outerwear (26.82%), Trousers (14.74%), T-shirts (12.68%), Knitwear (7.25%), Shirts (4.46%), Other business revenue (3.34%), and Suits (2.72%).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10